Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
29 May 2026, 16:05:16 UTC
Prior SEC filing
21 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Michael B. Hoffman

Key filing fact

Michael B. Hoffman filed Form 4 for Translational Development Acquisition Corp. (TDAC) on 29 May 2026.

Key facts

  • This page summarizes Michael B. Hoffman's Form 4 filing for Translational Development Acquisition Corp. (TDAC).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 29 May 2026, 16:05.

Change

  • Previous filing in this sequence was filed on 21 May 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001290208 Primary reporting owner

Hoffman Michael B

Relationship
Chairman and CEO, Director
Address
C/O TRANSLATIONAL DEVELOPMENT ACQ CORP., 52 E. 83RD STREET, NEW YORK
Signature
/s/ Michael B. Hoffman
Signature date
29 May 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TDAC transaction Derivative

Warrants

Purchase

Transaction value
Shares
+53,395
Change %
Price
$0.7918*
Shares after
53,395
Date
27 May 2026
Ownership
Direct
Underlying class
Class A ordinary shares
Underlying amount
53,395
Exercise price
$11.50
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each warrant becomes exercisable 30 days after completion of the Issuer's initial business combination, as described in the Issuer's filings with the Securities and Exchange Commission. The warrants expire five years after completion of the Issuer's initial business combination, or earlier upon redemption or liquidation, as described in the Issuer's filings with the Securities and Exchange Commission (the "SEC")

Footnote F2

The price reported in Column 8 is a weighted average price. These warrants were purchased in multiple transactions at prices ranging from $0.71 to $0.9997, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of warrants purchased at each separate price within the range set forth in this footnote. For reference, aggregate proceeds were $42,280.50 and the exact weighted average price was $0.7918438056.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .